Immunocytochemistry Test of Protein BRAF Expression for Diagnosis of Well Differentiated Thyroid Carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Immunocytochemistry Test of Protein BRAF Expression for Diagnosis of Well Differentiated Thyroid Carcinoma ; volume:11 ; number:3 ; year:2018 ; pages:843-849
Case reports in oncology ; 11, Heft 3 (2018), 843-849
- Urheber
-
Sudarsa, I. Wayan
Pualillin, Elvis Deddy Kurniawan
Adiputra, Putu Anda Tusta
Manuaba, Ida Bagus Tjakra Wibawa
- DOI
-
10.1159/000495029
- URN
-
urn:nbn:de:101:1-2019010923222962918461
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sudarsa, I. Wayan
- Pualillin, Elvis Deddy Kurniawan
- Adiputra, Putu Anda Tusta
- Manuaba, Ida Bagus Tjakra Wibawa
Ähnliche Objekte (12)
Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer
Well-differentiated (Marschalko-type) plasmacytoma resembling thyroid follicular structures
Establishing a Cutoff Serum Thyroglobulin Value for the Diagnosis and Management of Well-Differentiated Thyroid Cancer
Helicase-like transcription factor: a new marker of well-differentiated thyroid cancers
Methylation status of TSHr in well-differentiated thyroid cancer by using cytologic material
Frozen section analysis and sentinel lymph node biopsy in well differentiated thyroid cancer
Preradioactive Iodine Thyroglobulin Levels as Predictors of Metastasis in Well-Differentiated Thyroid Carcinoma Patients
Targeting NG2 relieves the resistance of BRAF-mutant thyroid cancer cells to BRAF inhibitors
Unusual Presentation of Differentiated Thyroid Cancer Metastasis
Poorly differentiated thyroid carcinoma : An underdiagnosed entity
Can preoperative thyroglobulin antibody levels be used as a marker for well differentiated thyroid cancer?
Dual EGFR and BRAF blockade overcomes resistance to vemurafenib in BRAF mutated thyroid carcinoma cells
Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer
Well-differentiated (Marschalko-type) plasmacytoma resembling thyroid follicular structures
Establishing a Cutoff Serum Thyroglobulin Value for the Diagnosis and Management of Well-Differentiated Thyroid Cancer
Helicase-like transcription factor: a new marker of well-differentiated thyroid cancers
Methylation status of TSHr in well-differentiated thyroid cancer by using cytologic material
Frozen section analysis and sentinel lymph node biopsy in well differentiated thyroid cancer
Preradioactive Iodine Thyroglobulin Levels as Predictors of Metastasis in Well-Differentiated Thyroid Carcinoma Patients
Targeting NG2 relieves the resistance of BRAF-mutant thyroid cancer cells to BRAF inhibitors
Unusual Presentation of Differentiated Thyroid Cancer Metastasis
Poorly differentiated thyroid carcinoma : An underdiagnosed entity
Can preoperative thyroglobulin antibody levels be used as a marker for well differentiated thyroid cancer?
Dual EGFR and BRAF blockade overcomes resistance to vemurafenib in BRAF mutated thyroid carcinoma cells
Classical V600E and other non-hotspot BRAF mutations in adult differentiated thyroid cancer
Well-differentiated (Marschalko-type) plasmacytoma resembling thyroid follicular structures
Establishing a Cutoff Serum Thyroglobulin Value for the Diagnosis and Management of Well-Differentiated Thyroid Cancer
Helicase-like transcription factor: a new marker of well-differentiated thyroid cancers
Methylation status of TSHr in well-differentiated thyroid cancer by using cytologic material
Frozen section analysis and sentinel lymph node biopsy in well differentiated thyroid cancer
Preradioactive Iodine Thyroglobulin Levels as Predictors of Metastasis in Well-Differentiated Thyroid Carcinoma Patients
Targeting NG2 relieves the resistance of BRAF-mutant thyroid cancer cells to BRAF inhibitors
Unusual Presentation of Differentiated Thyroid Cancer Metastasis
Poorly differentiated thyroid carcinoma : An underdiagnosed entity
Can preoperative thyroglobulin antibody levels be used as a marker for well differentiated thyroid cancer?